https://chinahealthreport.com/article/905530195-ainnocence-peptideai-platform-screens-3-2m-peptides-with-90-accuracy-in-activity-and-therapeutic-property-predictions China Health Report en PressRelease 2026-04-15T16:00:00+00:00 Ainnocence PeptideAI Platform screens 3.2M peptides with 90%+ accuracy in activity and therapeutic property predictions https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832514-peptide-ai-flyer-2026-854x1220.png https://chinahealthreport.com/article/905887680-peripheral-nerve-injury-market-growth-overview-facts-figures-segmentation-future-trends-historical-analysis-by-2033 China Health Report en PressRelease 2026-04-15T13:17:58+00:00 Peripheral Nerve Injury Market Growth Overview, Facts & Figures, Segmentation, Future Trends Historical Analysis By 2033 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833356-peripheral-nerve-injury-market-1024x1024.jpeg https://chinahealthreport.com/article/905791055-epimab-biotherapeutics-to-present-a-novel-prodrug-t-cell-engager-protce-platform-at-the-2026-american-association-for-cancer-research-annual-meeting China Health Report en PressRelease 2026-04-15T01:00:00+00:00 EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting https://ml.globenewswire.com/media/fa1bd13e-e49a-4b2c-a742-85957a03ad87/small/epimab-logo-for-notified-png.png